Medgenics, Inc. announced that Andrew L. Pearlman retired from the Board of Directors at the Annual Meeting of Stockholders held on April 8, 2014.
Aevi Genomic Medicine, Inc.
Equities
US00835P1057
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |